gadopiclenol gadopiclenol gadopiclenol, sold under the brand name elucirem among others, is a contrast agent used with magnetic resonance imaging (mri) to detect and visualize lesions with abnormal vascularity in the central nervous system and in the body. gadopiclenol is a paramagnetic macrocyclic non-ionic complex of gadolinium. gadopiclenolclinical datatrade nameselucirem, vuewayahfs/drugs.commicromedex detailed consumer informationlicense data us dailymed: gadopiclenol routes ofadministrationintravenousatc codev08ca12 (who) legal statuslegal status us: ℞-only pharmacokinetic datametabolismnoneexcretionkidneysidentifiers iupac name 2--3,6,9,15-tetrazabicyclopentadeca-1(15),11,13-trien-6-yl]-5-(2,3-dihydroxypropylamino)-5-oxopentanoate;gadolinium(3+) cas number933983-75-6pubchem cid16223405chemspider17350646uniis276568koykeggd12435chemical and physical dataformulac35h54gdn7o15molar mass970.10 g·mol−13d model (jsmol)interactive image smiles .occ(o)cnc(=o)ccc(n1ccn(cc2cccc(cn(cc1)c(ccc(=o)ncc(o)co)c(=o))n2)c(ccc(=o)ncc(o)co)c(=o))c(=o) inchi inchi=1s/c35h57n7o15.gd/c43-19-24(46)14-36-30(49)7-4-27(33(52)53)40-10-12-41(28(34(54)55)5-8-31(50)37-15-25(47)20-44)17-22-2-1-3-23(39-22)18-42(13-11-40)29(35(56)57)6-9-32(51)38-16-26(48)21-45;/h1-3,24-29,43-48h,4-21h2,(h,36,49)(h,37,50)(h,38,51)(h,52,53)(h,54,55)(h,56,57);/q;+3/p-3key:gnrqmlrozpoldg-uhfffaoysa-k gadopiclenol was approved for medical use in the united states in september 2022. names gadopiclenol is the international nonproprietary name (inn).